Stereotactic Body Radiation Therapy Boost in Locally Advanced Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 5, 2009, Pages 1456-1461

  Seo, YoungSeok ^a   Kim, Mi Sook ^a   Yoo, SungYul ^a   Cho, ChulKoo ^a   Yang, KwangMo ^a   Yoo, HyungJun ^a   Choi, ChulWon ^a   Lee, DongHan ^a   Kim, Jin ^a   Kim, Min Suk ^a   Kang, HyeJin ^a   Kim, YoungHan ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

CyberKnife; Pancreatic cancer; Radiation therapy; Stereotactic

Indexed keywords

CLINICAL APPLICATION; CYBERKNIFE; OVERALL SURVIVAL; PANCREATIC CANCERS; PHASE II; PROGNOSTIC FACTORS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION THERAPY; STEREOTACTIC BODY RADIATION THERAPY; TOTAL DOSE;

CARBOHYDRATES; CHEMOTHERAPY; TOXICITY;

RADIOTHERAPY;

ANALGESIC AGENT; CA 19-9 ANTIGEN; GEMCITABINE; GIMERACIL; OTERACIL POTASSIUM; TEGAFUR; TS 1; UNCLASSIFIED DRUG; URACIL DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BYPASS SURGERY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; DUODENUM OBSTRUCTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MALE; NAUSEA; OVERALL SURVIVAL; PAIN; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INDUCED EMESIS; RADIATION INJURY; RETROSPECTIVE STUDY; RISK FACTOR; STEREOTACTIC BODY RADIATION THERAPY; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CA-19-9 ANTIGEN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OXONIC ACID; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOSURGERY; RETROSPECTIVE STUDIES; TEGAFUR; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 71649106367     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.01.042     Document Type: Article

References (30)

1. Cress R.D., Yin D., Clarke L., et al. Survival among patients with adenocarcinoma of the pancreas: A population-based study (United States). Cancer Causes Control 17 (2006) 403-409
2. Beger H.G., Rau B., Gansauge F., et al. Treatment of pancreatic cancer: Challenge of the facts. World J Surg 27 (2003) 1075-1084
3. Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. gastrointestinal tumor study group. J Natl Cancer Inst 80 (1988) 751-755
4. Li C.P., Chao Y., Chi K.H., Chan W.K., et al. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study. Int J Radiat Oncol Biol Phys 57 (2003) 98-104
5. Willett C.G., Del Castillo C.F., Shih H.A., et al. Long-term results of intraoperative electron beam irradiation (IOERT) for patients with unresectable pancreatic cancer. Ann Surg 241 (2005) 295-299
6. Isacoff W.H., Bendetti J.K., Barstis J.J., et al. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. J Clin Oncol 25 (2007) 1665-1669
7. Choi C., Kim M., Cho C., et al. Locally advanced, unresectable pancreatic cancer treated by stereotactic radiation therapy. J Korean Soc Ther Radiol Oncol 24 (2006) 11-20
8. Bai Y.R., Wu G.H., Guo W.J., et al. Intensity modulated radiation therapy and chemotherapy for locally advanced pancreatic cancer: Results of feasibility study. World J Gastroenterol 9 (2003) 2561-2564
9. Goldstein D., Van Hazel G., Walpole E., et al. Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer. Br J Cancer 97 (2007) 464-471
10. Murphy J.D., Adusumilli S., Griffith K.A., et al. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 68 (2007) 801-808
11. Furuse J., Kinoshita T., Kawashima M., et al. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma. Cancer 97 (2003) 1346-1352
12. Haddock M.G., Swaminathan R., Foster N.R., et al. Gemcitabine, cisplatin, and radiotherapy for patients with locally advanced pancreatic adenocarcinoma: Results of the North Central Cancer Treatment Group Phase II Study N9942. J Clin Oncol 25 (2007) 2567-2572
13. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC cancer staging manual 6th ed (2002), Springer-Verlag, New York
14. Kim J.G., Lee D.H., and Kim M.S. A study of the reduction of organ motion from respiration. Korea J Med Phys 15 (2004) 179-186
15. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. european organization for research and treatment of cancer, national cancer institute of the united states, national cancer institute of canada. J Natl Cancer Inst 92 (2000) 205-216
16. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
17. National Database at the Ministry of Internal Affairs (2008), Ministry of Public Administration and Security, Korea. http://www.mopas.go.kr/gpms/index.jsp Accessed July 16, 2008
18. Sultana A., Tudur Smith C., Cunningham D., et al. Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy. Br J Cancer 96 (2007) 1183-1190
19. Yip D., Karapetis C., Strickland A., et al. Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer. Cochrane Database Syst Rev 3 (2006) CD002093
20. Ben-Josef E., Lawrence T.S., and Zalupski M.M. Radiotherapy for locally advanced pancreatic cancer. J Clin Oncol 25 (2007) 4861
21. Spalding A.C., Jee K.W., Vineberg K., et al. Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions. Med Phys 34 (2007) 521-529
22. D'Souza W.D., Nazareth D.P., Zhang B., et al. The use of gated and 4D CT imaging in planning for stereotactic body radiation therapy. Med Dosim 32 (2007) 92-101
23. Casamassima F., Cavedon C., Francescon P., et al. Use of motion tracking in stereotactic body radiotherapy: Evaluation of uncertainty in off-target dose distribution and optimization strategies. Acta Oncol 45 (2006) 943-947
24. Koong A.C., Christofferson E., Le Q.T., Goodman K.A., et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 63 (2005) 320-323
25. Hoyer M., Roed H., Sengelov L., et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother Oncol 76 (2005) 48-53
26. Koong A.C., Le Q.T., Ho A., et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1017-1021
27. Schellenberg D., Goodman K.A., Lee F., et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 72 (2008) 678-686
28. Nishiyama Y., Yamamoto Y., Yokoe K., et al. Contribution of whole body FDG-PET to the detection of distant metastasis in pancreatic cancer. Ann Nucl Med 19 (2005) 491-497
29. Wakabayashi H., Nishiyama Y., Otani T., et al. Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancer. World J Gastroenterol 14 (2008) 64-69
30. Casneuf V., Delrue L., Kelles A., et al. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?. Acta Gastroenterol Belg 70 (2007) 331-338